MedTrace Logo

Digestive Properties of Carbohydrate-based Foods

NCT03630458 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-08-22

No results posted yet for this study

Summary

Gastric emptying rate, glycemic response, fermentation, and appetitive response are being assessed after consumption of traditional West African carbohydrate-based foods (pearl millet couscous, pearl millet thick porridge) and Western type carbohydrate-based foods (wheat couscous, white rice).

Conditions

  • Obesity
  • Diabetes Mellitus, Type 2
  • Appetitive Behavior

Interventions

OTHER

Pearl millet couscous - made in Senegal

Pearl millet couscous (made in Senegal) was tested for gastric emptying rate, glycemic response, fermentability, and appetitive response.

OTHER

Pearl millet couscous - made in USA

Pearl millet couscous (made in USA) was tested for gastric emptying rate, glycemic response, fermentability, and appetitive response.

OTHER

Pearl millet thick porridge

Pearl millet thick porridge was tested for gastric emptying rate, glycemic response, fermentability, and appetitive response.

OTHER

Wheat couscous

Wheat couscous was tested for gastric emptying rate, glycemic response, fermentability, and appetitive response.

OTHER

White rice

White rice was tested as a comparator for gastric emptying rate, glycemic response, fermentability, and appetitive response.

Sponsors & Collaborators

  • Purdue University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-11
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03630458 on ClinicalTrials.gov